Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)
This funding opportunity supports research to understand why sporadic (non-hereditary) early-onset cancers are rising in people ages 18–49, including the causes, biological mechanisms, and approaches for earlier detection and risk identification. Projects may study environmental or lifestyle exposures, investigate host and tumor biology driving increased incidence, and develop strategies to id…
Source
Dates
Eligibility
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
National Institutes of Health
-
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
National Institutes of Health
-
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
National Institutes of Health
-
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
National Institutes of Health
-
Cancer Health Research Centers (CHERCs)
American Cancer Society
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers